iCAD, Inc.

iCAD, Inc.verified

ICAD

Price:

$1.6601

Market Cap:

$44.06M

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFo...[Read more]

Industry

Medical - Devices

IPO Date

1984-12-13

Stock Exchange

NASDAQ

Ticker

ICAD

The ROE as of September 2024 (TTM) for iCAD, Inc. (ICAD) is -9.30%

According to iCAD, Inc.’s latest financial reports and current stock price. The company's current ROE is -9.30%. This represents a change of 282.20% compared to the average of -2.43% of the last 4 quarters.

iCAD, Inc. (ICAD) Historical ROE (quarterly & annually)

How has ICAD ROE performed in the past?

The mean historical ROE of iCAD, Inc. over the last ten years is -78.21%. The current -9.30% ROE has changed -88.11% with respect to the historical average. Over the past ten years (40 quarters), ICAD's ROE was at its highest in in the December 2023 quarter at 4.08%. The ROE was at its lowest in in the March 2019 quarter at -81.41%.

Quarterly (TTM)
Annual

Average

-78.21%

Median

-49.01%

Minimum

-267.23%

Maximum

-1.61%

iCAD, Inc. (ICAD) ROE by Quarter and Year

Discovering the peaks and valleys of iCAD, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.07%

Maximum Annual ROE = -1.61%

Minimum Annual Increase = -95.48%

Minimum Annual ROE = -267.23%

Quarterly (TTM)
Annual
YearROEChange
2023-22.26%-43.11%
2022-39.13%61.85%
2021-24.17%-58.10%
2020-57.69%-78.41%
2019-267.23%104.37%
2018-130.76%30.94%
2017-99.86%147.58%
2016-40.33%-59.29%
2015-99.09%6.07%
2014-1.61%-95.48%

iCAD, Inc. (ICAD) Average ROE

How has ICAD ROE performed in the past?

The current ROE of iCAD, Inc. (ICAD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-28.52%

5-year avg

-82.10%

10-year avg

-78.21%

iCAD, Inc. (ICAD) ROE vs. Peers

How is ICAD’s ROE compared to its peers?

iCAD, Inc.’s ROE is greater than Profound Medical Corp. (-71.94%), greater than SI-BONE, Inc. (-24.27%), greater than Sight Sciences, Inc. (-45.68%), greater than Nevro Corp. (-27.37%), greater than Paragon 28, Inc. (-33.34%), greater than STRATA Skin Sciences, Inc. (-69.56%), less than Sientra, Inc. (414.58%), greater than AxoGen, Inc. (-17.30%), greater than Ainos, Inc. (-64.53%), greater than LENSAR, Inc. (-30.16%), less than Aziyo Biologics, Inc. (196.38%), greater than INVO Bioscience, Inc. (-1073.76%), greater than enVVeno Medical Corporation (-54.24%), greater than Establishment Labs Holdings Inc. (-220.67%), greater than CVRx, Inc. (-77.62%), less than Surgalign Holdings, Inc. (416.30%), greater than Surmodics, Inc. (-1.16%), greater than Biomerica, Inc. (-69.21%), greater than Movano Inc. (-452.96%),

Build a custom stock screener for iCAD, Inc. (ICAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iCAD, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iCAD, Inc. (ICAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iCAD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is iCAD, Inc.'s ROE?

How is the ROE calculated for iCAD, Inc. (ICAD)?

What is the highest ROE for iCAD, Inc. (ICAD)?

What is the 3-year average ROE for iCAD, Inc. (ICAD)?

What is the 5-year average ROE for iCAD, Inc. (ICAD)?

How does the current ROE for iCAD, Inc. (ICAD) compare to its historical average?